ММВБ 2 750 0,6%  Nasdaq 9 552 0,7%  Биткойн 10 065 -1,3%  USD/RUB 69,1055 0,0% 
РТС 1 248 2,3%  S&P500 3 056 0,4%  Нефть 38,6 -0,1%  EUR/RUB 76,8925 -0,1% 
Dow 25 475 0,4%  FTSE100 6 166 1,5%  Золото 1 740 0,0%  EUR/USD 1,1126 -0,1% 

Курс акций Catalyst Pharmaceutical Partners [ISIN: US14888U1016]

купить
продать

Catalyst Pharmaceutical Partners Inc. - Профиль

Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasmsThe company was founded Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.

Акционеры

Название Доля (%)
Freefloat93,11
Consonance Capital Management LP17,36
Armistice Capital LLC5,20
Armistice Capital LLC4,86
Patrick J. McEnany4,62
Vanguard Group, Inc. (Subfiler)4,54
Avoro Capital Advisor LLC4,38
State Street Corp.3,52
BlackRock Fund Advisors3,49
BlackRock Institutional Trust Co. NA2,77
Vanguard Total Stock Market Index Fund2,71
Morgan Stanley Smith Barney LLC2,54
Mangrove Partners2,44
iShares Russell 2000 ETF2,14
Opaleye Management, Inc.1,78

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент